Purchase Order 75F40126P00250

The Food and Drug Administration awarded a purchase order to Emulate Inc. for $45,000 on August 28, 2025, for the procurement of organ-on-chip culture modules, specifically two Emulate Zoe CM1 units and one Orb Hub Module-1. The contract is structured as a firm fixed-price purchase order with an ultimate completion date of August 28, 2026, and performance will take place at the FDA's facility in Silver Spring, Maryland. No set-aside designation was used for this award. Emulate Inc., a...

The Food and Drug Administration awarded a firm fixed-price purchase order to Emulate Inc. for $213,100 on August 14, 2023, to provide a human emulation system including an Orb-HM1 hub module (used), two ZOE-CM2 culture modules (used), one new ZOE-CM2 culture module with one-year warranty, and a service agreement covering the three used items. The order carried a total small business set-aside. Work is performed in Boston, Massachusetts, with an ultimate completion date of August 14, 2024. The...

The Department of Health and Human Services Food and Drug Administration awarded a $149,130 firm fixed price purchase order to Emulate Inc., doing business as Emulate, for the delivery of a CDER-2023-117371-ZOE MODULE (ZOE-CM2) WITH AN ORB HUB (ORB-HM1) MCMI23 - ROBUST ORGAN-ON-A-CHIP SYSTEM FOR BIOASSAY DEVELOPMENT. This award responds to Solicitation 75F40123Q00376 which sought a robust organ-on-a-chip system to support the FDA's bioassay development work. Place of performance will be...

The Food and Drug Administration awarded a $19,266.67 firm fixed-price purchase order to Emulate Inc., a Boston-based biotechnology company specializing in organ-on-chip microphysiological systems. The contract, posted in February 2023 with an award date of April 20, 2023, provides a full-service preventative maintenance agreement for two Zoe Culture Modules and two Orb Hub Modules through a base year plus four option years. The contract utilizes no set-aside designation and specifies...

The Food and Drug Administration awarded a purchase order to Emulate Inc. for two Human Emulation System Zoe Culture Module 2 units and two Orb Hub Modules, with a ceiling value of $141,448.33 and an award date of June 9, 2023. The order carries a Total Small Business set-aside. Performance occurs in Boston, Massachusetts. The award was ultimately completed on August 11, 2025. This modification de-obligates funds, cancels non-funded line items 6 and 7, and closes out the contract. Pricing is...

The U.S. Food and Drug Administration awarded a $200.3K purchase order to Emulate Inc., a Boston-based biotechnology company specializing in organ-on-chip microphysiological systems, for the procurement of a Human Emulation System. The contract, awarded on March 29, 2023, with an ultimate completion date of October 1, 2023, carries a Total Small Business set-aside designation and employs firm fixed-price pricing. The award supports FDA's regulatory science initiatives and efforts to advance...

The Food and Drug Administration awarded a $248,000 firm fixed price purchase order to Emulate Inc. for Emulate Chip-S1 Basic Research Kits on September 19, 2025. The contract, with an ultimate completion date of September 18, 2026, will be performed at the FDA's Silver Spring, Maryland location. No set-aside designation was applied to this procurement. Emulate Inc., headquartered in Boston, Massachusetts, is a biotechnology company specializing in organ-on-chip microphysiological systems that...

The Food and Drug Administration awarded a $31,950 purchase order to Emulate Inc. on June 18, 2025, for twelve Chip-R1 Rigid Chip basic research kits under a total small business set-aside designation. The contract, which extends to October 16, 2025, represents a firm fixed price procurement of the company's organ-on-chip technology. Emulate Inc., headquartered in Boston, Massachusetts, specializes in microphysiological systems that replicate human organ functions to support advanced...

The Food and Drug Administration awarded a purchase order to Emulate Inc. for five Liver Human Emulation System 24 Pack Quad Liver Chip Kits valued at $104,500 on June 27, 2023, with ultimate completion June 26, 2024. The award carries a Total Small Business set-aside. Performance occurs in Boston, Massachusetts. Emulate is a Boston-based small business specializing in organ-on-chip microphysiological systems for drug development and regulatory science applications. The firm-fixed-price purchase...

The Department of Health and Human Services Food and Drug Administration awarded a $354,235 purchase order to Emulate Inc., doing business as Emulate, located in Boston, Massachusetts. The firm fixed price contract is for a Liver Human Emulation System to support the FDA's regulatory review processes. Per the original solicitation, the agency sought to procure a Liver-Chip, Quad-Culture Kits, Zoe Culture Modules, an Orb Hub Module and associated equipment with a simple user interface and small...